Cargando…
Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687261/ https://www.ncbi.nlm.nih.gov/pubmed/23359361 http://dx.doi.org/10.2337/dc12-2294 |
_version_ | 1782273890617131008 |
---|---|
author | Wu, Tongzhi Bound, Michelle J. Zhao, Beiyi R. Standfield, Scott D. Bellon, Max Jones, Karen L. Horowitz, Michael Rayner, Christopher K. |
author_facet | Wu, Tongzhi Bound, Michelle J. Zhao, Beiyi R. Standfield, Scott D. Bellon, Max Jones, Karen L. Horowitz, Michael Rayner, Christopher K. |
author_sort | Wu, Tongzhi |
collection | PubMed |
description | OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4). We evaluated the effects of a low-energy d-xylose preload, with or without sitagliptin, on gastric emptying, plasma intact GLP-1 concentrations, and postprandial glycemia in type 2 diabetes. RESEARCH DESIGN AND METHODS: Twelve type 2 diabetic patients were studied on four occasions each. After 100 mg sitagliptin (S) or placebo (P) and an overnight fast, patients consumed a preload drink containing either 50 g d-xylose (X) or 80 mg sucralose (control [C]), followed after 40 min by a mashed potato meal labeled with (13)C-octanoate. Blood was sampled at intervals. Gastric emptying was determined. RESULTS: Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05). The postprandial insulin-to-glucose ratio was attenuated (P < 0.05) and gastric emptying was slower (P < 0.01) after d-xylose, without any effect of sitagliptin. Plasma GLP-1 concentrations were higher after d-xylose than control only before the meal (P < 0.05) but were sustained postprandially when combined with sitagliptin (P < 0.05). CONCLUSIONS: In type 2 diabetes, acute administration of a d-xylose preload reduces postprandial glycemia and enhances the effect of a DPP-4 inhibitor. |
format | Online Article Text |
id | pubmed-3687261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-36872612014-07-01 Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes Wu, Tongzhi Bound, Michelle J. Zhao, Beiyi R. Standfield, Scott D. Bellon, Max Jones, Karen L. Horowitz, Michael Rayner, Christopher K. Diabetes Care Original Research OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4). We evaluated the effects of a low-energy d-xylose preload, with or without sitagliptin, on gastric emptying, plasma intact GLP-1 concentrations, and postprandial glycemia in type 2 diabetes. RESEARCH DESIGN AND METHODS: Twelve type 2 diabetic patients were studied on four occasions each. After 100 mg sitagliptin (S) or placebo (P) and an overnight fast, patients consumed a preload drink containing either 50 g d-xylose (X) or 80 mg sucralose (control [C]), followed after 40 min by a mashed potato meal labeled with (13)C-octanoate. Blood was sampled at intervals. Gastric emptying was determined. RESULTS: Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05). The postprandial insulin-to-glucose ratio was attenuated (P < 0.05) and gastric emptying was slower (P < 0.01) after d-xylose, without any effect of sitagliptin. Plasma GLP-1 concentrations were higher after d-xylose than control only before the meal (P < 0.05) but were sustained postprandially when combined with sitagliptin (P < 0.05). CONCLUSIONS: In type 2 diabetes, acute administration of a d-xylose preload reduces postprandial glycemia and enhances the effect of a DPP-4 inhibitor. American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687261/ /pubmed/23359361 http://dx.doi.org/10.2337/dc12-2294 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Wu, Tongzhi Bound, Michelle J. Zhao, Beiyi R. Standfield, Scott D. Bellon, Max Jones, Karen L. Horowitz, Michael Rayner, Christopher K. Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title | Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title_full | Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title_fullStr | Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title_full_unstemmed | Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title_short | Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes |
title_sort | effects of a d-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687261/ https://www.ncbi.nlm.nih.gov/pubmed/23359361 http://dx.doi.org/10.2337/dc12-2294 |
work_keys_str_mv | AT wutongzhi effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT boundmichellej effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT zhaobeiyir effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT standfieldscottd effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT bellonmax effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT joneskarenl effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT horowitzmichael effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes AT raynerchristopherk effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes |